Farmak JSC increased its medicine sales by 18.35%
Farmak JSC increased sales of medicines by 18.35%
According to the results of Q1 2018, Farmak JSC increased its sales by 18.35% to 1.1 billion UAH against Q1 2017. Proxima Research data.
“For eight years straight now Farmak has been the leader on the pharmaceutical market of the country*. The company has achieved such results due to quality and innovation. Over the past seven years Farmak has spent 2.8 billion hryvnyas on the development and modernization of production. Today, all the equipment of the Company is high-tech and ultra-modern. Production lines meet GMP, ISO requirements. Farmak’s focus is the manufacture of innovative biotech products. These include Flenox, insulin and its analogues, X-ray contrast agents. At the same time, we continue to produce basic drugs that have been on the market for a few decades,” said Volodymyr Kostiuk, acting Executive Director of Farmak JSC.
TOP 100. The Ratings of the Largest published the Employer Brand Rating and the Rating of TOP 30 Best HR Directors in Ukraine. According to the magazine, Farmak is one of three companies providing the best working conditions, and Viktoria Kondrashykhina, HR Director of Farmak, became the best HR director in the pharmaceutical industry. The […]
The HR Director of Farmak was included in the Rating of TOP 30 Best HR Directors of Ukraine according to TOP-100. The Ratings of the Largest. Viktoria Kondrashykhina is the only one in this list who represents the pharmaceutical industry. The rating of the Best HR Directors was based on: voting of readers on […]
Focus presented the industry rating of Ukraine’s top managers. According to the magazine, the Executive Director of Farmak is one of the leading managers of the pharmaceutical industry. Focus selected the most important markets for the Ukrainian economy based on their contribution to GDP. They were 13 sectors: agricultural, financial, manufacturing industry,...